jueves, 15 de agosto de 2019

Novartis broke sacred FDA rule: In God we trust, all others must bring data

Novartis broke sacred FDA rule: In God we trust, all others must bring data

Daily Recap

Opinion: Novartis violated FDA’s sacred principle: In God we trust, all others must bring data

By ROBERT M. CALIFF


ANDREW HARNIK/AP
The FDA's independent evaluation of science is an essential part of its dual role in protecting public health and promoting innovation.

No hay comentarios: